PedAM
Pediatric Disease Annotations & Medicines
| Disease | breast cancer |
| Symptom | C0746883|febrile neutropenia |
| Sentences | 7 |
| PubMedID- 20180162 | Pegfilgrastim vs filgrastim in primary prophylaxis of febrile neutropenia in patients with breast cancer after chemotherapy: a cost-effectiveness analysis for germany. |
| PubMedID- 23468242 | Chronic comorbid conditions associated with risk of febrile neutropenia in breast cancer patients treated with chemotherapy. |
| PubMedID- 26532561 | Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast cancer in greece. |
| PubMedID- 21706156 | Mdm2 snp309 and tp53 r72p associated with severe and febrile neutropenia in breast cancer patients treated with 5-fu/epirubicin/cyclophosphamide. |
| PubMedID- 26251780 | The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort study. |
| PubMedID- 24888663 | Chemotherapy-induced febrile neutropenia in patients with breast cancer. |
| PubMedID- 25556610 | Recent data on the national estimates of mortality rate, length of stay, and health care costs among the subpopulation of febrile neutropenia admissions with breast cancer are lacking. |
Page: 1